BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 20629366)

  • 1. Smokeless tobacco: challenges, products and, cessation.
    Rankin KV; Jones DL; Benton E
    Tex Dent J; 2010 Jun; 127(6):589-94. PubMed ID: 20629366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing smokeless tobacco products new tobacco-delivery systems.
    Hatsukami DK; Ebbert JO; Feuer RM; Stepanov I; Hecht SS
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S368-78. PubMed ID: 18021912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smokeless tobacco use: harm reduction or induction approach?
    Hatsukami DK; Lemmonds C; Tomar SL
    Prev Med; 2004 Mar; 38(3):309-17. PubMed ID: 14766113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smokeless tobacco cessation guidelines for health professionals in England.
    West R; McNeill A; Raw M;
    Br Dent J; 2004 May; 196(10):611-8. PubMed ID: 15153967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smokeless tobacco: an emerging addiction.
    Ebbert JO; Carr AB; Dale LC
    Med Clin North Am; 2004 Nov; 88(6):1593-605. PubMed ID: 15464115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smokeless tobacco use by youth: a health concern.
    Johnson GK; Squier CA
    Pediatr Dent; 1993; 15(3):169-74. PubMed ID: 8378153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
    Alpert HR; Koh H; Connolly GN
    Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral health risks of tobacco use and effects of cessation.
    Warnakulasuriya S; Dietrich T; Bornstein MM; Casals Peidró E; Preshaw PM; Walter C; Wennström JL; Bergström J
    Int Dent J; 2010 Feb; 60(1):7-30. PubMed ID: 20361572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPIT TOBACCO: A Changing Landscape.
    Rankin KV
    Tex Dent J; 2015 Aug; 132(8):510-6. PubMed ID: 26489289
    [No Abstract]   [Full Text] [Related]  

  • 13. Tobacco cessation in the dental office.
    Albert D; Ward A
    Dent Clin North Am; 2012 Oct; 56(4):747-70. PubMed ID: 23017549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smokeless tobacco addiction: a threat to the oral and systemic health of the child and adolescent.
    Christen AG; McDonald JL; Olson BL; Christen JA
    Pediatrician; 1989; 16(3-4):170-7. PubMed ID: 2692003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spit tobacco: content, nicotine delivery, health effects, and cessation.
    Holyfield LJ
    Tex Dent J; 2005 Jun; 122(6):536-42. PubMed ID: 16114705
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
    Richter P; Hodge K; Stanfill S; Zhang L; Watson C
    Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral screening and brief spit tobacco cessation counseling: a review and findings.
    Gansky SA; Ellison JA; Kavanagh C; Hilton JF; Walsh MM
    J Dent Educ; 2002 Sep; 66(9):1088-98. PubMed ID: 12374270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts.
    Levy DT; Mumford EA; Cummings KM; Gilpin EA; Giovino G; Hyland A; Sweanor D; Warner KE
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2035-42. PubMed ID: 15598758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smokeless tobacco: epidemiology, health effects and cessation strategies.
    Spangler JG; Salisbury PL
    Am Fam Physician; 1995 Oct; 52(5):1421-30, 1433-4. PubMed ID: 7572565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.